Creighton CJ - Search Results

1

SGK3 is associated with estrogen receptor expression in breast cancer.

Xu J, Wan M, He Q, Bassett RL Jr, Fu X, Chen AC, Shi F, Creighton CJ, Schiff R, Huo L, Liu D. Xu J, et al. Among authors: creighton cj. Breast Cancer Res Treat. 2012 Jul;134(2):531-41. doi: 10.1007/s10549-012-2081-x. Epub 2012 May 11. Breast Cancer Res Treat. 2012. PMID: 22576469 Free PMC article.

2

Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.

Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D. Creighton CJ, et al. Cancer Res. 2006 Apr 1;66(7):3903-11. doi: 10.1158/0008-5472.CAN-05-4363. Cancer Res. 2006. PMID: 16585219

3

When will tumor gene expression profiling be incorporated into clinical breast cancer decision making?

Creighton CJ, Rae JM. Creighton CJ, et al. Breast Cancer Res. 2006;8(4):302. doi: 10.1186/bcr1519. Breast Cancer Res. 2006. PMID: 16834787 Free PMC article.

4

A gene transcription signature of the Akt/mTOR pathway in clinical breast tumors.

Creighton CJ. Creighton CJ. Oncogene. 2007 Jul 12;26(32):4648-55. doi: 10.1038/sj.onc.1210245. Epub 2007 Jan 8. Oncogene. 2007. PMID: 17213801

5

A gene transcription signature associated with hormone independence in a subset of both breast and prostate cancers.

Creighton CJ. Creighton CJ. BMC Genomics. 2007 Jun 28;8:199. doi: 10.1186/1471-2164-8-199. BMC Genomics. 2007. PMID: 17598908 Free PMC article.

6

Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function.

Massarweh S, Osborne CK, Creighton CJ, Qin L, Tsimelzon A, Huang S, Weiss H, Rimawi M, Schiff R. Massarweh S, et al. Among authors: creighton cj. Cancer Res. 2008 Feb 1;68(3):826-33. doi: 10.1158/0008-5472.CAN-07-2707. Cancer Res. 2008. PMID: 18245484

7

Molecular profiles of progesterone receptor loss in human breast tumors.

Creighton CJ, Kent Osborne C, van de Vijver MJ, Foekens JA, Klijn JG, Horlings HM, Nuyten D, Wang Y, Zhang Y, Chamness GC, Hilsenbeck SG, Lee AV, Schiff R. Creighton CJ, et al. Breast Cancer Res Treat. 2009 Mar;114(2):287-99. doi: 10.1007/s10549-008-0017-2. Epub 2008 Apr 19. Breast Cancer Res Treat. 2009. PMID: 18425577 Free PMC article.

8

Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis.

Creighton CJ, Casa A, Lazard Z, Huang S, Tsimelzon A, Hilsenbeck SG, Osborne CK, Lee AV. Creighton CJ, et al. J Clin Oncol. 2008 Sep 1;26(25):4078-85. doi: 10.1200/JCO.2007.13.4429. J Clin Oncol. 2008. PMID: 18757322 Free PMC article.

9

Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts.

Creighton CJ, Massarweh S, Huang S, Tsimelzon A, Hilsenbeck SG, Osborne CK, Shou J, Malorni L, Schiff R. Creighton CJ, et al. Cancer Res. 2008 Sep 15;68(18):7493-501. doi: 10.1158/0008-5472.CAN-08-1404. Cancer Res. 2008. PMID: 18794137 Free PMC article.

10

Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers.

Creighton CJ, Fountain MD, Yu Z, Nagaraja AK, Zhu H, Khan M, Olokpa E, Zariff A, Gunaratne PH, Matzuk MM, Anderson ML. Creighton CJ, et al. Cancer Res. 2010 Mar 1;70(5):1906-15. doi: 10.1158/0008-5472.CAN-09-3875. Epub 2010 Feb 23. Cancer Res. 2010. PMID: 20179198 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters